- $1.37bn
- $1.37bn
- 45
- 30
- 64
- 43
2020 December 31st | C2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | 10-K/A | 10-K/A | |
Standards: | — | USG | USG |
Status: | fx Preliminary | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | — | 0.328 | 0.001 |
Total Other Current Assets | |||
Total Current Assets | — | 0.569 | 0.169 |
Long Term Investments | |||
Other Long Term Assets | |||
Total Assets | — | 294 | 300 |
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | — | 1.25 | 23.5 |
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | — | 11.3 | 33.5 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | — | 283 | 267 |
Total Liabilities & Shareholders' Equity | — | 294 | 300 |
Total Common Shares Outstanding |